知镜 Cognispect · 医学文献与研究工作台

Hematologic Malignancies With RUNX1::ZFPM2 Translocation: A Case Report and Literature Review.

Temple M, Vazquez R, Balducci E, Couronné L, Birsen R, Roupie AL, Decroocq J, Rodier C, Willems L, Chapuis N, Almire C, Boussaid I, Fontenay M, Bouscary D, Kosmider O, Friedrich C.
EJHaem · 2026-10-16 · PMID 42890877

文献摘要

RUNX1 rearrangements are recurrent in myeloid neoplasms, but rare fusion partners remain poorly characterized. We report the first acute myeloid leukemia (AML) with a RUNX1::ZFPM2 fusion generated by t(8;21)(q23;q22). A 72-year-old woman presented with acute myelomonocytic leukemia carrying concomitant IDH2 and NRAS mutations. Azacitidine-venetoclax induced transient remission with a marked decrease in the fusion transcript. However, persistent cytopenias, molecular relapse, and treatment resistance led to death 1 year after diagnosis. This case expands the spectrum of RUNX1 -rearranged AML and suggests a biological behavior distinct from classical RUNX1::RUNX1T1 -positive AML. Trial registration The authors have confirmed clinical trial registration is not needed for this submission.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。